In early 2022, four new grants were awarded to advance research in FA cancer preclinical models, Fanconi Anemia Neurological Syndrome (FANS), and mental health.
Trials investigating the FDA-approved drug metformin and the natural antioxidant quercetin were funded in early 2018.
Throughout the month of May, FARF supporters all of the world join in to raise funds and awareness. FA means #FindAnswers and #FightAlways.
We are very pleased to welcome friend and supporter Aileen Carlos to the Board of Directors. Aileen is a lawyer based in Portland, Ore.
Dr. Robert Ferris of the University of Pittsburgh will chair the meeting of 20+ head and neck experts from around the world.
We are pleased to welcome longtime FARF supporter and FA parent Orion Marx to the Board of Directors.
The grant will allow FARF to generate greater income to support its mission to find effective treatments and a cure for FA and to provide education and support services to affected families worldwide.